444 related articles for article (PubMed ID: 23563622)
1. Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin.
Palazzuoli A; Masson S; Ronco C; Maisel A
Heart Fail Rev; 2014 Mar; 19(2):267-84. PubMed ID: 23563622
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.
Buglioni A; Burnett JC
Clin Chim Acta; 2015 Mar; 443():3-8. PubMed ID: 25445413
[TBL] [Abstract][Full Text] [Related]
3. Change in the NT-proBNP/Mature BNP Molar Ratio Precedes Worsening Renal Function in Patients With Acute Heart Failure: A Novel Predictor Candidate for Cardiorenal Syndrome.
Takahama H; Nishikimi T; Takashio S; Hayashi T; Nagai-Okatani C; Asada T; Fujiwara A; Nakagawa Y; Amano M; Hamatani Y; Okada A; Amaki M; Hasegawa T; Kanzaki H; Nishimura K; Yasuda S; Kangawa K; Anzai T; Minamino N; Izumi C
J Am Heart Assoc; 2019 Sep; 8(17):e011468. PubMed ID: 31441355
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis of acute heart failure and relevance of biomarkers in elderly patients].
Ruiz Ortega RA; Manzano L; Montero-Pérez-Barquero M
Med Clin (Barc); 2014 Mar; 142 Suppl 1():20-5. PubMed ID: 24930079
[TBL] [Abstract][Full Text] [Related]
5. Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes.
Cruz DN; Goh CY; Palazzuoli A; Slavin L; Calabrò A; Ronco C; Maisel A
Heart Fail Rev; 2011 Nov; 16(6):545-51. PubMed ID: 21298337
[TBL] [Abstract][Full Text] [Related]
6. The impact of kidney dysfunction categorized by urinary to serum creatinine ratio on clinical outcomes in patients with heart failure.
Otaki Y; Watanabe T; Konta T; Tamura H; Kato S; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Watanabe M
Heart Vessels; 2020 Feb; 35(2):187-196. PubMed ID: 31332507
[TBL] [Abstract][Full Text] [Related]
7. Management of chronic heart failure: biomarkers, monitors, and disease management programs.
Gandhi PU; Pinney S
Ann Glob Health; 2014; 80(1):46-54. PubMed ID: 24751564
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers for acute cardiorenal syndrome.
Fan PC; Chang CH; Chen YC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():68-71. PubMed ID: 30298648
[TBL] [Abstract][Full Text] [Related]
9. The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?
Triposkiadis F; Starling RC; Boudoulas H; Giamouzis G; Butler J
Heart Fail Rev; 2012 May; 17(3):355-66. PubMed ID: 22086438
[TBL] [Abstract][Full Text] [Related]
10. The Cardiorenal Syndrome: Mechanistic Insights and Prognostication with Soluble Biomarkers.
Seliger S
Curr Cardiol Rep; 2020 Aug; 22(10):114. PubMed ID: 32770361
[TBL] [Abstract][Full Text] [Related]
11. The combined measurement of high-sensitivity cardiac troponins and natriuretic peptides: a useful tool for clinicians?
Perrone MA; Zaninotto M; Masotti S; Musetti V; Padoan A; Prontera C; Plebani M; Passino C; Romeo F; Bernardini S; Clerico A
J Cardiovasc Med (Hagerstown); 2020 Dec; 21(12):953-963. PubMed ID: 33156589
[TBL] [Abstract][Full Text] [Related]
12. The cardiorenal problem.
Pollock E; Nowak A
Swiss Med Wkly; 2014; 144():w14051. PubMed ID: 25473886
[TBL] [Abstract][Full Text] [Related]
13. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
[TBL] [Abstract][Full Text] [Related]
14. Circulating biomarkers in patients with heart failure and preserved ejection fraction.
O'Meara E; de Denus S; Rouleau JL; Desai A
Curr Heart Fail Rep; 2013 Dec; 10(4):350-8. PubMed ID: 24122286
[TBL] [Abstract][Full Text] [Related]
15. Novel heart failure biomarkers: why do we fail to exploit their potential?
Piek A; Du W; de Boer RA; Silljé HHW
Crit Rev Clin Lab Sci; 2018 Jun; 55(4):246-263. PubMed ID: 29663841
[TBL] [Abstract][Full Text] [Related]
16. Sex-Related Aspects of Biomarkers in Cardiac Disease.
Mingels AMA; Kimenai DM
Adv Exp Med Biol; 2018; 1065():545-564. PubMed ID: 30051406
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers in heart failure: the past, current and future.
Sarhene M; Wang Y; Wei J; Huang Y; Li M; Li L; Acheampong E; Zhengcan Z; Xiaoyan Q; Yunsheng X; Jingyuan M; Xiumei G; Guanwei F
Heart Fail Rev; 2019 Nov; 24(6):867-903. PubMed ID: 31183637
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of cardiac and kidney dysfunction in cardiorenal syndromes.
Cruz DN; Soni S; Slavin L; Ronco C; Maisel A
Contrib Nephrol; 2010; 165():83-92. PubMed ID: 20427958
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.
Zachariah D; Olechowski B; Kalra PR
J Ren Care; 2013 Sep; 39(3):128-39. PubMed ID: 23902278
[TBL] [Abstract][Full Text] [Related]
20. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides.
Maeder M; Fehr T; Rickli H; Ammann P
Chest; 2006 May; 129(5):1349-66. PubMed ID: 16685029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
